Boris Duchemann

5.5k citations
102 papers · 4.0k · 3 hit papers · h-index 26

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Lung Cancer Treatments and Mutations
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in

    • Lung Cancer Treatments and Mutations 29
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 15
    • Lung Cancer Diagnosis and Treatment 12
    • Tracheal and airway disorders 5
    • Occupational and environmental lung diseases 5
    • Cancer Immunotherapy and Biomarkers 19
    • Lung Cancer Research Studies 14

Boris Duchemann

95 papers receiving 3.9k citations

Boris Duchemann's Hit Papers

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial 2021 · 229 citations
2290+2+5Years since publication100200300400500

Peers

Boris Duchemann
Comparison fields: 5 of 110
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 1.2k
  • Infectious Diseases 615
  • Neurology 322
  • Immunology 438
Replace Spasenija Savic with:
Spasenija Savic Switzerland
Émeline Colomba France
Zongan Liang China
Camillo Ribi Switzerland
Roni F. Rayes Canada
Federica Zoratto Italy
Karen M. Convery United States
Vincenzo Montesarchio Italy
Jin‐Sook Ryu South Korea
Da Xu China
Boris Duchemann relative to Spasenija Savic Switzerland Spasenija Savic's profile →
Citations per field
00.5×2×3×4.4×
Spasenija Savic · 1×
Citations per year

Countries citing papers authored by Boris Duchemann

Since Specialization
Citations

This map shows the geographic impact of Boris Duchemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Duchemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Duchemann more than expected).

Fields of papers citing papers by Boris Duchemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Duchemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Duchemann. The network helps show where Boris Duchemann may publish in the future.

Co-authors

The 25 scholars most cited alongside Boris Duchemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Boris Duchemann Line = papers co-authored together Boris Duchemann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Hit paper breakdown →
2020589
2
Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Hit paper breakdown →
2018580
3 2012451
4
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Hit paper breakdown →
2021229
5 2017219
6 2019198
7 2020140
8 2019130
9 202083
10 201975
11 202157
12 202356
13 202455
14 202054
15 201952
16 202352
17 202450
18 202243
19 201738
20 201936

About Boris Duchemann

Boris Duchemann is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Physiology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 102 papers that have together received 4.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Cancer Immunotherapy and Biomarkers (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Lung Cancer Research Studies (14 papers), Lung Cancer Diagnosis and Treatment (12 papers), Tracheal and airway disorders (5 papers), Occupational and environmental lung diseases (5 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.2k citations), Infectious Diseases (615 citations), Neurology (322 citations) and Immunology (438 citations). Boris Duchemann has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Kader Chouahnia, Laurent H. Zelek, Michaël Soussan, Lucas Goldfarb, CHRISTOS CHOUAID, Jean‐Baptiste Assié, Benjamin Besse, Thierry Landre, Hilario Nunès and Laura Mezquita. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Cancers, Lung Cancer and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact